New research reveals that patients who come off popular slimming jabs like Mounjaro or Wegovy tend to recover shed pounds much more quickly than those who end conventional lifestyle regimens.
Published data in a prominent medical journal shows that while overweight individuals frequently drop about a fifth of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month after stopping.
"Individuals purchasing these medications must be cognizant of the potential of rapid rebound weight gain when the treatment concludes," warns researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment weight within about a year and a half.
Analyzing Approaches
The research, which reviewed 37 of trials involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.
Scientists emphasize that people who shed pounds through lifestyle changes alone usually see a slower weight regain—approximately 0.1 kg a month—post-intervention.
Understanding the Fast Rebound
Nutrition scientists believe the mechanism of the drugs accounts for the heightened weight return.
The injections mimic a natural hormone called GLP-1, which controls hunger.
"Long-term administration of the hormone levels several times higher than the body's typical production could lead to the body to produce less of its own natural hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' results in appetite is no longer kept in check, making binge eating a significant risk."
A Lifelong Condition?
Health authorities suggest the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
Professionals say that, due to the likelihood of relapse, the treatment might need to be ongoing.
This opinion is reinforced by drug manufacturers, who say that the results "emphasize the long-term nature of obesity," akin to managing diseases like hypertension.
User Accounts
Individuals who have discontinued the medication report a powerful resurgence of appetite.
"It felt as if something that goes on and I was suddenly ravenous," recalled an individual.
The struggle is compounded if individuals have not established sustainable lifestyle or habit modifications during therapy.
Widespread Interest
Recent estimates suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is higher among females than men.
- The 40s and 50s age group shows the greatest level of interest.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, researchers emphasize that while GLP-1 drugs are powerful tools for weight loss, they are not a magic solution and long-term success relies on combined lifestyle management.
